CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 31 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $18,000 | -99.2% | 20,000 | -99.2% | 0.00% | -100.0% |
Q1 2019 | $2,211,000 | -34.4% | 2,379,000 | -40.7% | 0.02% | -33.3% |
Q4 2018 | $3,370,000 | +8541.0% | 4,015,000 | +11052.8% | 0.03% | – |
Q2 2018 | $39,000 | -93.3% | 36,000 | -92.8% | 0.00% | -100.0% |
Q1 2018 | $584,000 | -80.4% | 500,000 | -77.3% | 0.00% | -78.6% |
Q4 2017 | $2,984,000 | +95.7% | 2,204,000 | +123.5% | 0.01% | +40.0% |
Q3 2017 | $1,525,000 | -56.6% | 986,000 | -63.7% | 0.01% | -61.5% |
Q1 2017 | $3,517,000 | +10.6% | 2,714,000 | -12.5% | 0.03% | +44.4% |
Q4 2016 | $3,181,000 | +178.3% | 3,100,000 | +85.5% | 0.02% | +157.1% |
Q1 2016 | $1,143,000 | – | 1,671,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $44,037,000 | 1.28% |
United Asset Strategies, Inc. | 1,955,000 | $1,758,000 | 0.35% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,992,000 | $1,773,000 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 2,664,000 | $2,398,000 | 0.08% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,170,000 | $1,953,000,000 | 0.04% |
MACKAY SHIELDS LLC | 110,000 | $101,000 | 0.00% |
UBS Group AG | 3,000 | $3,000 | 0.00% |
NOMURA HOLDINGS INC | 68,267 | $5,000 | 0.00% |
ROYAL BANK OF CANADA | 1,000 | $1,000 | 0.00% |
FMR LLC | 1,728,000 | $1,556,000 | 0.00% |